Here's Why Lonza Group (LZAGY) Is a Great 'Buy the Bottom' Stock Now

Clinical OMICsCAR T-Cell Therapy Expands Access to Kidney Transplants

Endpoints NewsAlnylam to pay $30M upfront to AI startup Inceptive in RNA R&D deal

FierceBiotechLilly, Boehringer to slash at least $1B each from planned investments in Germany

Clinical OMICsGenetically Raised Pulse Pressure Predisposes to Dementia-Linked Death

Clinical OMICsEngineered Islets Could Eliminate Need for Immunosuppression in Type 1 Diabetes

FierceBiotechUnlocking Unstructured Data with AI for Optimized Protocol Development

Endpoints NewsBristol Myers turns focus to AI costs after broad rollout to workers

Clinical OMICsNew Tumor Survival Mechanism Revealed in Aggressive ALT Cancers

Clinical OMICsVeracyte Launches Test Identifying Breast Cancer Patients Who Don’t Need Chemo

Endpoints NewsAxsome pushes back generic entry for narcolepsy drug until 2040

Clinical OMICsNanotube Sensor Provides Chemical Imaging for Earlier Detection of Bladder Cancer Recurrence

Endpoints NewsFDA guides pharma on explaining unapproved drugs to payors